ArticleFrontiers in pharmacology2023

Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial.

Eman El-Khateeb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.